Dr. Reddy’s Q3 and 9M FY16 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Dow tick higher as investors weigh Mideast negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Dr. Reddys Labs (RDY) Reports Q3 EPS of $0.51
February 9, 2016 7:22 AM ESTDr. Reddys Labs (NYSE: RDY) reported Q3 EPS of $0.51, versus $0.51 reported last year. Revenue for the quarter came in at $599 million, versus $581 million reported last year.
For earnings history and earnings-related data on Dr. Reddys Labs (RDY) click here.
... More